An Act amending the act of May 13, 2008 (P.L.139, No.14), known as the Cancer Drug Repository Program Act, further providing for title and short title of act, for definitions, for establishment, for restocking and dispensing of cancer drugs, for storage, distribution and fees and for immunity; providing for annual report, for list of approved participating pharmacies and for limitations; further providing for regulations; and imposing duties on the State Board of Pharmacy.

Summary

The bill amends Pennsylvania’s Cancer Drug Repository Act, renaming it the Cancer Prescription Drug Repository Program and giving the State Board of Pharmacy authority to run it. Eligible pharmacies can receive unopened, unexpired donated cancer drugs and dispense them to low‑income patients, with the board handling reporting, oversight, and limited liability for participants.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share